Last reviewed · How we verify

Use of Intraoperative Intravenous Fentanyl

University of Sao Paulo General Hospital · FDA-approved active Small molecule Quality 2/100

Use of Intraoperative Intravenous Fentanyl is a Small molecule drug developed by University of Sao Paulo General Hospital. It is currently FDA-approved. Also known as: Methadone.

At a glance

Generic nameUse of Intraoperative Intravenous Fentanyl
Also known asMethadone
SponsorUniversity of Sao Paulo General Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Use of Intraoperative Intravenous Fentanyl

What is Use of Intraoperative Intravenous Fentanyl?

Use of Intraoperative Intravenous Fentanyl is a Small molecule drug developed by University of Sao Paulo General Hospital.

Who makes Use of Intraoperative Intravenous Fentanyl?

Use of Intraoperative Intravenous Fentanyl is developed and marketed by University of Sao Paulo General Hospital (see full University of Sao Paulo General Hospital pipeline at /company/university-of-sao-paulo-general-hospital).

Is Use of Intraoperative Intravenous Fentanyl also known as anything else?

Use of Intraoperative Intravenous Fentanyl is also known as Methadone.

What development phase is Use of Intraoperative Intravenous Fentanyl in?

Use of Intraoperative Intravenous Fentanyl is FDA-approved (marketed).

Related